MC1525A1 - Preparation d'une composition pour le traitement de la seborrhee - Google Patents

Preparation d'une composition pour le traitement de la seborrhee

Info

Publication number
MC1525A1
MC1525A1 MC831646A MC1646A MC1525A1 MC 1525 A1 MC1525 A1 MC 1525A1 MC 831646 A MC831646 A MC 831646A MC 1646 A MC1646 A MC 1646A MC 1525 A1 MC1525 A1 MC 1525A1
Authority
MC
Monaco
Prior art keywords
compound
composition
tetrahydro
local administration
approximately
Prior art date
Application number
MC831646A
Other languages
English (en)
French (fr)
Inventor
Alfred Boris
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1525A1 publication Critical patent/MC1525A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/47Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing ten carbon atoms
    • C07C13/48Completely or partially hydrogenated naphthalenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dental Preparations (AREA)
MC831646A 1982-07-02 1983-06-30 Preparation d'une composition pour le traitement de la seborrhee MC1525A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39475482A 1982-07-02 1982-07-02

Publications (1)

Publication Number Publication Date
MC1525A1 true MC1525A1 (fr) 1984-04-13

Family

ID=23560291

Family Applications (1)

Application Number Title Priority Date Filing Date
MC831646A MC1525A1 (fr) 1982-07-02 1983-06-30 Preparation d'une composition pour le traitement de la seborrhee

Country Status (30)

Country Link
US (1) US4588750A (enExample)
JP (1) JPS5921630A (enExample)
KR (1) KR840005341A (enExample)
AR (1) AR230180A1 (enExample)
AU (1) AU565242B2 (enExample)
BE (1) BE897195A (enExample)
BR (1) BR8303529A (enExample)
CA (1) CA1221032A (enExample)
CH (1) CH654287A5 (enExample)
DE (1) DE3323585A1 (enExample)
DK (1) DK291583A (enExample)
DO (1) DOP1983004277A (enExample)
ES (1) ES8700049A1 (enExample)
FI (1) FI832432A7 (enExample)
FR (1) FR2529458B1 (enExample)
GB (1) GB2123692B (enExample)
GR (1) GR79328B (enExample)
IE (1) IE55206B1 (enExample)
IL (1) IL69118A (enExample)
IT (1) IT1169742B (enExample)
LU (1) LU84892A1 (enExample)
MC (1) MC1525A1 (enExample)
NL (1) NL8302346A (enExample)
NO (1) NO832417L (enExample)
NZ (1) NZ204767A (enExample)
PH (1) PH19249A (enExample)
PT (1) PT76974B (enExample)
SE (1) SE453636B (enExample)
ZA (1) ZA834804B (enExample)
ZW (1) ZW15183A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
CA1268124A (en) * 1985-06-28 1990-04-24 Werner Bollag Use of a retinoid
CA1268125A (en) * 1985-06-28 1990-04-24 F. Hoffmann-La Roche Ag Use of a retinoid
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
DE3903989A1 (de) * 1989-02-10 1990-09-20 Basf Ag Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
DE3903988A1 (de) * 1989-02-10 1990-08-30 Basf Ag Oxidierte diphenylheteroalkane, ihre herstellung und verwendung
DE3903990A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
DE3903991A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone des (beta)-jonons, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
GB9315156D0 (en) * 1993-07-22 1993-09-08 Ici Plc Coating compositions
DE10016625A1 (de) 2000-04-04 2001-10-11 Basell Polyolefine Gmbh Gasphasenpolymerisationsverfahren mit Direktkühlsystem
AU2003301240A1 (en) * 2002-05-20 2004-05-04 William O. Kling Skin cleanser compositions and methods of use
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
US20050180940A1 (en) * 2004-02-17 2005-08-18 Puma Jeffrey P. Protect against hair loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060228A1 (de) * 1970-12-08 1972-06-15 Hoechst Ag Monostyryl-naphthalin-Derivate,Verfahren zu deren Herstellung und ihre Verwendung als optische Aufhellungsmittel
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
DK159967C (da) * 1977-12-22 1991-06-03 Hoffmann La Roche Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater

Also Published As

Publication number Publication date
DOP1983004277A (es) 1990-03-20
FR2529458B1 (fr) 1986-10-24
KR840005341A (ko) 1984-11-12
DE3323585A1 (de) 1984-01-05
FR2529458A1 (fr) 1984-01-06
CH654287A5 (de) 1986-02-14
AU565242B2 (en) 1987-09-10
ZA834804B (en) 1984-03-28
AU1646583A (en) 1984-01-05
AR230180A1 (es) 1984-03-01
FI832432L (fi) 1984-01-03
IE55206B1 (en) 1990-07-04
IT8321896A0 (it) 1983-07-01
BE897195A (fr) 1984-01-02
SE453636B (sv) 1988-02-22
PT76974A (en) 1983-08-01
IL69118A (en) 1986-07-31
JPS5921630A (ja) 1984-02-03
PH19249A (en) 1986-02-14
BR8303529A (pt) 1984-02-07
DK291583D0 (da) 1983-06-23
NL8302346A (nl) 1984-02-01
DK291583A (da) 1984-01-03
GB8317991D0 (en) 1983-08-03
ES523760A0 (es) 1986-10-16
GB2123692B (en) 1986-07-09
PT76974B (en) 1986-06-26
GR79328B (enExample) 1984-10-22
ZW15183A1 (en) 1985-01-23
NZ204767A (en) 1986-06-11
US4588750A (en) 1986-05-13
NO832417L (no) 1984-01-03
CA1221032A (en) 1987-04-28
IL69118A0 (en) 1983-10-31
ES8700049A1 (es) 1986-10-16
GB2123692A (en) 1984-02-08
FI832432A7 (fi) 1984-01-03
SE8303732D0 (sv) 1983-06-30
IE831548L (en) 1984-01-02
FI832432A0 (fi) 1983-07-01
IT1169742B (it) 1987-06-03
SE8303732L (sv) 1984-01-03
LU84892A1 (fr) 1985-03-29

Similar Documents

Publication Publication Date Title
BE1004155A3 (fr) Composition pharmaceutique et cosmetique anti-acneique.
CA2174598C (fr) Utilisation d'un inhibiteur d'hmg-coenzyme a-reductase pour lutter contre le vieillissement de la peau_ou stimuler le processus de renouvellement epidermique
MC1525A1 (fr) Preparation d'une composition pour le traitement de la seborrhee
BE1004154A4 (fr) Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique.
CH660687A5 (fr) Composition anti-acneique a base de peroxyde de benzoyle et d'au moins un filtre solaire.
CH657987A5 (fr) Composition anti-acneique a base de peroxyde de benzoyle et d'au moins un autre principe actif.
FR2523443A1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
FR2747568A1 (fr) Utilisation d'au moins un inhibiteur de lipoxygenase et d'au moins un inhibiteur de cyclo-oxygenase pour modifier la pousse des poils et/ou des cheveux
FR2679140A1 (fr) Composition cosmetique ou dermatologique depigmentante contenant des derives d'arbutoside.
FR2514643A1 (fr) Lanolate de cuivre et compositions cosmetiques anti-acneiques le contenant
CA2099473C (fr) Composition cosmetique et/ou dermatologique a action depigmentante contenant un acide di- ou tri-cafeoylquinique ou un melange de ceux-ci
CH671577A5 (enExample)
BE898315A (fr) Composition anti-acnéique contenant en tant que composé actif un dérivé d'isothiazolo- (5,4b) pyridine one-3.
EP2114387B1 (fr) Utilisation de compositions comprenant au moins une lignane et/ou neolignane pour moduler le taux de testosterone
FR2502006A1 (fr) Composes polyprenyliques favorisant la guerison des plaies et compositions les contenant
FR2806301A1 (fr) Composition a base de sphingolipide et de beta-hydroxy-acide utilisable par voie topique pour les soins de la peau
EP0223671A1 (fr) Médicament à action synergétique anti-inflammatoire à base d'un corticostéroide et d'un beta-agoniste
EP1068865B1 (fr) Utilisation de l'acide 4,6-diméthoxy-indole 2-carboxylique ou de ses dérivés pour le traitement de la séborrhée
FR2773074A1 (fr) Composition a base d'alpha-hydroxy-acides et de ceramides utilisable par voie topique pour le traitement d'affections dermatologiques
FR2679132A1 (fr) Utilisation de derives du benzofuranne dans des compositions cosmetiques ou dermatologiques, comme agents depigmentants.
CA1144072A (fr) Compositions pharmaceutiques et cosmetiques
EP0753341A1 (fr) Utilisation de composés hydrofluocarbonés à fonction thioester dans des émulsions, applications cosmétiques ou dermatologiques
WO2001026619A2 (fr) Composition, notamment cosmetique, renfermant la dhea et un agent desquamant
FR2933300A1 (fr) Compositions comprenant au moins une lignane et/ou neolignane en association avec un compose actif contre l'acne
LU86393A1 (fr) Composition anti-acneique stable a base d'erythromycine

Legal Events

Date Code Title Description
YP Annual fee paid